Evolving Landscapes in Mitigating Coronary Obstruction for Transcatheter Aortic Valve Replacement (TAVR) Authors: Ho-On Alston Conrad Chiu, Simon Cheung-Chi Lam, Ka-Chun Un Published: 2026 ABSTRACT Corresponding Author Amidst advancements in technology and maturation of techniques for transcatheter aortic valve replacement (TAVR), coronary obstruction (CO), with incidence of 0.62% in native TAVR and 2.5% in valve-in-valve TAVR, remains a devastating complication.1 Factors that predict CO risks include low coronary height (<10 mm), narrow sinuses, increased leaflet-to-sinus ratio, low valve-to-coronary distance, low valve-to-sinotubular junction (<2 mm), and others.1, 2, 3 Novel prediction models that identify new risk markers have also been reported.4 In a study by Khan et al,4 a multivariate model using combined computed tomography–based parameters, including cusp height (cusp height > coronary height), virtual valve-to-coronary distance of ≤4 mm, and culprit leaflet calcium volume (>600 mm3), performed well in predicting coronary obstruction (areas under the curve of 0.93 for left coronary artery and 0.94 for right coronary artery). To mitigate CO, different strategies have been developed (Figure 1).Figure 1Evolving Landscapes in Mitigating Coronary Obstruction During TAVR(A) Timeline showing advents of strategies that mitigate coronary obstruction. (B) Strategies mitigating coronary obstruction include 1) preemptive coronary wiring and chimney stenting, 2) leaflet modification techniques (LMTs), and 3) percutaneous aorto-coronary bypass. TAVR = transcatheter aortic valve replacement. Evolving Landscapes in Mitigating Coronary Obstruction During TAVR (A) Timeline showing advents of strategies that mitigate coronary obstruction. (B) Strategies mitigating coronary obstruction include 1) preemptive coronary wiring and chimney stenting, 2) leaflet modification techniques (LMTs), and 3) percutaneous aorto-coronary bypass. TAVR = transcatheter aortic valve replacement. Coronary Protection, Chimney Stenting, and Orthotopic Stenting Before the emergence of leaflet modification techniques (LMTs), coronary protection via preemptive coronary wiring before transcatheter heart valve (THV) deployment has been adopted in patients with high CO risks.1, 2, 3 In case of CO following TAVR, subsequent stent deployment across the aorta and coronary ostia may be performed to preserve coronary flow. In this issue of JACC: Case Reports, Nguyen et al5 described 2 cases of CO following TAVR, assessed by both angiography and intravascular ultrasound (IVUS), with subsequent chimney stenting. Multimodality imaging, as highlighted in the article, is paramount in guiding the need for chimney stenting.5 Conventionally, angiographic evidence of critical ostial stenosis, sinus sequestration, or impaired coronary flow (≤TIMI II), prompt the need for chimney stenting.2,3 Adding incremental value to angiographical assessment, IVUS enables visualization of leaflet material within or near coronary ostia, identification of leaflet tissue proximity to aortic wall, and recognition of small residual cross-sectional area in the paraostial space following TAVR.2,3 These aforementioned features, which are not discernible on angiography alone, may further compel chimney stenting.2,3 Furthermore, to facilitate potential chimney stenting, IVUS may be used to evaluate coronary ostia size for optimal stent selection before THV deployment.2,3 Although studies have demonstrated procedural effectiveness of chimney stenting (clinical success rates of 97.2%), concerns regarding long-term durability, stent deformation, and stent thrombosis remain for such strategy.2,3,6 In contrast to chimney stenting, which involves stent implantation within the space between the aortic wall and THV frame, orthotopic-snorkel stenting involves stent deployment across the aortic root and coronary ostia through the THV frame.2,6,7 As an alternative bailout strategy for CO, orthotopic stenting enables a more physiologic TAVR-stent configuration.7,8 Emergence of LMTs Alternative strategies for mitigating CO that the authors and other operators may consider is LMT.9, 10, 11, 12, 13, 14, 15, 16, 17 LMT can be largely classified as electrosurgical laceration-based and balloon-based techniques. Other LMT and dedicated leaflet modifying devices also have been reported.16,17 Pioneer to all aortic valve LMTs, bioprosthetic or native aortic scallop intentional laceration to prevent iatrogenic coronary artery obstruction (BASILICA) modifies target leaflet(s) through leaflet laceration electrosurgically.9,10 By pulling an electrified wire shaped in a Flying-V configuration, created through target leaflet traversal and externalization of the traversal wire, target leaflet laceration is achieved.9,10 Registries have demonstrated the effectiveness of BASILICA, with procedural success rates of more than 90% across the globe.10 Variations such as balloon-augmented BASILICA, coronary anchor wiring technique, and aortic snaring variants (chordal-zone free externalization of retrograde wire technique) have been shown to be effective as well.11, 12, 13 Undermining iatrogenic coronary obstruction with radiofrequency needle (UNICORN, 2022) was developed as the first and foremost balloon-based LMT in the aortic position.14,15 UNICORN modifies the target leaflet through intraleaflet deployment of balloon-expandable THV within a de novo fenestration, created via serial balloon dilatation of the target leaflet traversal point.14,15 Such strategy enables simultaneous laceration and entrapment of the target leaflet.14,15 Early registries demonstrated safety and effectiveness of UNICORN.15,18 Dedicated leaflet modification devices like the ShortCut device, which mechanically lacerates the target leaflet through splitting elements of the device, also have been developed and reported.17 Although BASILICA and UNICORN reduce the neoskirt area, there is still a small risk of CO.8 Thus, it is essential to adapt cautious coronary protection, along with multimodality imaging including IVUS assessment, as the authors reported.5 If CO risk is identified, the splayed leaflet facilitates orthotopic stenting.8 Novel Strategies and Future Directions More recently, the ventriculo-coronary transcatheter outward navigation and reentry (2026) procedure, a percutaneous aorto-coronary bypass technique, was developed and reported as a novel strategy to mitigate CO during TAVR.19 Nonetheless, experience for the technique remains minimal and it is less likely to be used in most anatomies.19 Conclusions Over the past decade, the advent of coronary protection strategies and LMTs has enabled TAVR to be performed in patients who were formerly deemed prohibitive.2,9,14 With growing numbers of strategies in mitigating CO during TAVR, selecting the optimal strategy becomes more challenging. Although direct comparison of existing techniques remains lacking, an international task force is proposing an algorithmic approach to facilitate selection of the optimal strategy.20 As new strategies emerge, new chapters unfold, shaping the evolving landscapes in mitigating CO in TAVR. Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.